Portage Biotech Inc (PRTG) — Financial Flexibility Index
Portage Biotech Inc (PRTG) has a Financial Flexibility Index of -0.78x as of September 2024. Free cash flow of $-1.56 Million (operating CF $-1.56 Million minus capex $0.00) represents -1% of total liabilities ($2.01 Million). Check PRTG capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Portage Biotech Inc Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Portage Biotech Inc across 27 annual periods. For the full cash flow conversion analysis, see Portage Biotech Inc (PRTG) cash flow conversion.
Annual Financial Flexibility Index for Portage Biotech Inc (1998–2025)
Year-by-year free cash flow to debt coverage for Portage Biotech Inc. Explore Portage Biotech Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.79x | $-5.46 Million | $-5.46 Million | $3.05 Million | ▲ +44.3% |
| 2024 | -3.21x | $-14.30 Million | $-14.30 Million | $4.45 Million | ▼ -531.8% |
| 2023 | -0.51x | $-12.07 Million | $-12.07 Million | $23.73 Million | ▼ -119.8% |
| 2022 | -0.23x | $-6.76 Million | $-6.76 Million | $29.23 Million | ▼ -92.1% |
| 2021 | -0.12x | $-3.28 Million | $-4.28 Million | $27.26 Million | ▲ +10.6% |
| 2020 | -0.13x | $-3.71 Million | $-3.71 Million | $27.53 Million | ▼ -295.2% |
| 2019 | -0.03x | $-858.00K | $-858.00K | $25.16 Million | ▲ +98.8% |
| 2018 | -2.79x | $-1.07 Million | $-1.07 Million | $384.00K | ▲ +34.6% |
| 2017 | -4.27x | $-1.32 Million | $-1.32 Million | $309.43K | ▲ +73.6% |
| 2016 | -16.14x | $-4.84 Million | $-5.84 Million | $299.74K | ▼ -283.3% |
| 2015 | -4.21x | $-2.61 Million | $-2.61 Million | $620.56K | ▲ +58.2% |
| 2014 | -10.08x | $-1.94 Million | $-1.94 Million | $191.97K | ▼ -151.6% |
| 2013 | -4.01x | $-1.79 Million | $-1.79 Million | $446.87K | ▼ -696.0% |
| 2012 | -0.50x | $-1.34 Million | $-1.34 Million | $2.66 Million | ▲ +85.1% |
| 2011 | -3.38x | $-2.30 Million | $-2.62 Million | $682.75K | ▼ -374.3% |
| 2010 | 1.23x | $4.25 Million | $-356.14K | $3.45 Million | ▲ +152.3% |
| 2009 | -2.35x | $-283.22K | $-287.38K | $120.39K | ▲ +70.8% |
| 2008 | -8.06x | $-462.10K | $-468.92K | $57.34K | ▲ +25.7% |
| 2007 | -10.84x | $-455.25K | $-458.84K | $42.00K | ▼ -161.5% |
| 2006 | 17.63x | $2.50 Million | $-645.50K | $141.52K | ▲ +3723.5% |
| 2004 | -0.49x | $-321.51K | $-321.51K | $660.63K | ▲ +22.5% |
| 2003 | -0.63x | $-146.90K | $-146.90K | $233.80K | ▲ +49.2% |
| 2002 | -1.24x | $-156.58K | $-156.80K | $126.48K | ▲ +65.1% |
| 2001 | -3.55x | $-335.67K | $-347.00K | $94.62K | ▼ -52.5% |
| 2000 | -2.33x | $-352.74K | $-466.90K | $151.67K | ▲ +54.3% |
| 1999 | -5.09x | $-331.22K | $-345.09K | $65.14K | ▼ -498.3% |
| 1998 | -0.85x | $-422.15K | $-422.97K | $496.67K | — |